FDA Inspection 1190279 — Reproductive Medicine Associates of Lehigh Valley
The FDA completed an inspection of Reproductive Medicine Associates of Lehigh Valley on October 19, 2022 in Allentown, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 19, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Allentown, PA (United States)